A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Diseases and Abnormal Conditions)
Heterozygote
Genotype
European Continental Ancestry Group
Molecular Sequence Data
610
Alleles; Australia; Base Sequence; Case-Control Studies; Chromosome Mapping; Confidence Intervals; Europe; European Continental Ancestry Group; Female; Gene Frequency; Genotype; Haplotypes; Heterozygote; Homozygote; Humans; Linkage Disequilibrium; Molecular Sequence Data; Odds Ratio; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; United States; Chromosomes, Human, Pair 9; Genetic Predisposition to Disease; Genome-Wide Association Study; Medicine (all); Genetics
Polymorphism, Single Nucleotide
Linkage Disequilibrium
618
03 medical and health sciences
0302 clinical medicine
Gene Frequency
Ovarian cancer
9201 Clinical Health (Organs
Risk Factors
616
Genetics
Confidence Intervals
Odds Ratio
Humans
Genetic Predisposition to Disease
111203 Cancer Genetics
Gene mapping
Alleles
Risk assessment
Ovarian Neoplasms
Base Sequence
Homozygote
Australia
Chromosome Mapping
United States
3. Good health
Europe
Haplotypes
Case-Control Studies
Female
CX
Chromosomes, Human, Pair 9
Genome-Wide Association Study
DOI:
10.1038/ng.424
Publication Date:
2009-08-02T17:37:21Z
AUTHORS (88)
ABSTRACT
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explain less than half the excess familial risk. We performed a genome-wide association study (GWAS) to identify common ovarian cancer susceptibility alleles. We evaluated 507,094 SNPs genotyped in 1,817 cases and 2,353 controls from the UK and approximately 2 million imputed SNPs. We genotyped the 22,790 top ranked SNPs in 4,274 cases and 4,809 controls of European ancestry from Europe, USA and Australia. We identified 12 SNPs at 9p22 associated with disease risk (P < 10(-8)). The most significant SNP (rs3814113; P = 2.5 x 10(-17)) was genotyped in a further 2,670 ovarian cancer cases and 4,668 controls, confirming its association (combined data odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.79-0.86, P(trend) = 5.1 x 10(-19)). The association differs by histological subtype, being strongest for serous ovarian cancers (OR 0.77, 95% CI 0.73-0.81, P(trend) = 4.1 x 10(-21)).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (251)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....